HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.990
-0.070 (-2.29%)
Oct 29, 2024, 4:00 PM EDT - Market closed
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
$1,240
Profits / Employee
-$486,003
Market Cap
2.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| iCoreConnect | 70 |
| iSpecimen | 53 |
| Scinai Immunotherapeutics | 31 |
| ReShape Lifesciences | 29 |
| Windtree Therapeutics | 20 |
| Bio-Path Holdings | 10 |
| Shuttle Pharmaceuticals Holdings | 8 |
| Virpax Pharmaceuticals | 7 |
HSCS News
- 15 days ago - HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 6 weeks ago - HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - GlobeNewsWire
- 3 months ago - HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - GlobeNewsWire
- 3 months ago - Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewsWire
- 3 months ago - HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewsWire
- 3 months ago - HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - GlobeNewsWire
- 5 months ago - HeartSciences Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire